India reported less than one lakh new coronavirus infections after a gap of 63 days, while the daily positivity rate dropped to 4.62 per cent, according to the Union Health Ministry data updated on Tuesday.
A single day rise of 86,498 cases were registered, the lowest in 66 days, taking the total tally of Covid-19 cases to 2,89,96,473.
The Covid-19 death toll climbed to 3,51,309 with 2,123 daily deaths, the lowest in 47 days, the data updated at 8 am showed.
A total of 81,466 new cases were recorded in a span of 24 hours on April 2.
Also, 18,73,485 tests were conducted on Monday taking the total cumulative tests conducted so far for detection of Covid-19 in the country to 36,82,07,596.
The daily positivity rate has dropped to 4.62 per cent . It has been less than 10 per cent for 15 consecutive days, the ministry said.
The weekly positivity rate has declined to 5.94 per cent.
The active cases reduced to 13,03,702 comprising 4.50 per cent of the total infections, while the national Covid-19 recovery rate has improved to 94.29 per cent.
A net decline of 97,907 cases has been recorded in the Covid-19 caseload in a span of 24 hours.
Since Monday, several states relaxed curbs and allowed a gradual unlocking of public services after a steady decline in cases even as some states extended lockdown-like restrictions. Prime Minister Narendra Modi, in a key announcement, on Monday declared free coronavirus vaccines to states and union territories for inoculation of all above 18 from June 21.
In an address to the nation, Modi also announced that the Centre has decided to buy 75 per cent of jabs from vaccine makers, including 25 per cent of the state quota, and give it for free to state governments, while private sector hospitals can continue to procure the remaining 25 per cent but cannot charge more than Rs 150 per dose over the pre-fixed price.
As India's Covid-19 cases see a dip and vaccinations pick up pace, albeit in a lopsided manner, worries still prevail over the real situation in rural areas, where access to healthcare facilities and actual testing rates and severity of infections remains unknown.
With PTI inputs